stock
QCLS · Q/C TECHNOLOGIES, INC.
What Q/C TECHNOLOGIES, INC. reports to the SEC, read from its filings.
Open in the appPrice
The live QCLS price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on QCLS.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 8,189,838 as of 2026-08-12 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- -37.2%
- Operating
- —
- Net
- —
Returns
- ROE
- -102.9%
- ROA
- -72.4%
Health
- Current ratio
- 3.3x
- Debt/equity
- —
Deep value
- NCAV
- $7.95M
- NCAV per share
- $0.97
- Price/NCAV
- Locked
- NNWC
- -$3.48M
- NNWC per share
- -$0.43
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | — | -$6.79M | -$6.62M | 10-Q filed 2026-08-12 |
| 2026-03-31 | — | — | -$1.86M | -$1.24M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | — | — | -$3.71M | -$5.89M | 10-K filed 2026-04-15 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | — | — | -$1.79M | -$2.81M | 10-Q filed 2025-11-19 |
| 2025-06-30 | — | — | -$1.87M | -$1.80M | 10-Q filed 2026-08-12 |
| 2025-03-31 | — | — | -$2.47M | -$1.12M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | — | — | -$2.19M | -$2.06M | 10-K filed 2026-04-15 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | — | — | -$1.83M | -$1.93M | 10-Q filed 2025-11-19 |
- Assets
- $22.87M
- Equity
- $16.09M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$9.85M | -$11.63M | — |
| 2024-12-31 | — | -$10.17M | -$23.36M | — |
| 2023-12-31 | — | -$17.12M | -$4.00M | — |
| 2022-12-31 | — | -$15.28M | -$15.20M | — |
| 2021-12-31 | — | -$28.81M | -$29.89M | — |
| 2020-12-31 | — | -$9.49M | -$9.49M | — |
| 2019-12-31 | $1.58M | -$3.47M | -$3.89M | — |
| 2018-12-31 | $1.67M | -$10.06M | -$10.85M | -$8.57M |
| 2017-12-31 | $3.35M | -$6.61M | -$7.37M | -$5.13M |
| 2016-12-31 | $2.96M | -$3.33M | -$3.30M | -$4.30M |
Company filings
since Wed Feb 11 · 1 offering filing in 12 months
events
Material agreement, Executive or director change, Regulation FD disclosure
Material agreementExecutive or director changeRegulation FD disclosureSep 188-KAgreement ended, Executive or director change
Agreement endedExecutive or director changeSep 118-KAgreement ended, Other event
Agreement endedOther eventJul 28-KAuditor change
Auditor changeMar 138-KMaterial agreement, Executive or director change, Other event
Material agreementExecutive or director changeOther eventJan 238-KMaterial agreement, Unregistered share sale, Other event
Material agreementUnregistered share saleOther event12/9/20258-K
5% owners ()
PharmaCyte Biotech, Inc.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
Couldn’t load politician trades
This read is unavailable. Try it again without changing anything on the page.
Funds
Couldn’t load funds
This read is unavailable. Try it again without changing anything on the page.
News
Stories that named QCLS, and the market events around them.
Sign in to see thisBoard
The QCLS board could not be loaded.
Retry the QCLS boardnakagai
Signals on QCLS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the QCLS board